(Q37567574)

English

Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease

scientific article published on December 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

6 references

13 March 2019

17 June 2019

2 October 2019

10 October 2019

11 October 2019

7 November 2019

Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease (English)

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

0 references

cardiovascular disease

6 references

13 March 2019

17 June 2019

2 October 2019

10 October 2019

11 October 2019

7 November 2019

chronic renal insufficiency

7 references

13 March 2019

17 June 2019

2 October 2019

10 October 2019

11 October 2019

7 November 2019

29 May 2020

mechanism of action

1 reference

2 October 2019

circulatory system

1 reference

10 October 2019

1 reference

11 October 2019

1 reference

7 November 2019

1 reference

based on heuristic

inferred from title

author name string

Anjay Rastogi

1

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 December 2013

8 references

Europe PubMed Central

PMC publication ID

21 August 2017

13 March 2019

17 June 2019

2 October 2019

10 October 2019

11 October 2019

7 November 2019

29 May 2020

Therapeutic advances in cardiovascular disease

8 references

Europe PubMed Central

PMC publication ID

21 August 2017

13 March 2019

17 June 2019

2 October 2019

10 October 2019

11 October 2019

7 November 2019

29 May 2020

7

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

322-342

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

copyright license

Creative Commons Attribution-NonCommercial 3.0 Unported

7 references

Europe PubMed Central

13 March 2019

Europe PubMed Central

17 June 2019

Europe PubMed Central

2 October 2019

Europe PubMed Central

10 October 2019

Europe PubMed Central

11 October 2019

Europe PubMed Central

7 November 2019

Europe PubMed Central

29 May 2020

on focus list of Wikimedia project

0 references

Managing chronic inflammation in the aging diabetic patient with CKD by diet or sevelamer carbonate: a modern paradigm shift

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

23 August 2017

Effects of phosphate binders in moderate CKD

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

23 August 2017

Dissociation between progression of coronary artery calcification and endothelial function in hemodialysis patients: a prospective pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

23 August 2017

Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

23 August 2017

Advanced glycation end products and diabetic cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

23 August 2017

Non-systemic drugs: a critical review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

23 August 2017

Vascular endothelial function is not related to serum uric acid in healthy adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

23 August 2017

Treatment of chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

23 August 2017

FGF23 induces left ventricular hypertrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

23 August 2017

Lanthanum carbonate, like sevelamer-HCl, retards the progression of vascular calcification and atherosclerosis in uremic apolipoprotein E-deficient mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

23 August 2017

Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

23 August 2017

Sevelamer and the bone-vascular axis in chronic kidney disease: bone turnover, inflammation, and calcification regulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

23 August 2017

Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

23 August 2017

A randomized, crossover design study of sevelamer carbonate powder and sevelamer hydrochloride tablets in chronic kidney disease patients on haemodialysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

23 August 2017

Dietary phosphorus acutely impairs endothelial function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

23 August 2017

Comparison of sevelamer hydrochloride and sevelamer carbonate: risk of metabolic acidosis and clinical implications.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

23 August 2017

Sevelamer decreases serum uric acid concentration through adsorption of uric acid in maintenance hemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

23 August 2017

Sevelamer carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

23 August 2017

Phosphorus binders and survival on hemodialysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

23 August 2017

Oxidative stress, inflammation and cardiovascular disease in chronic renal failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

23 August 2017

Use of sevelamer hydrochloride as an oxalate binder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

23 August 2017

Vitamin D receptor activation and survival in chronic kidney disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

23 August 2017

Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

23 August 2017

Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

23 August 2017

Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

23 August 2017

Effects of sevelamer and calcium-based phosphate binders on lipid and inflammatory markers in hemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

23 August 2017

Advanced glycation end products and nephrotoxicity of high-protein diets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

23 August 2017

Pleiotropic effects of the non-calcium phosphate binder sevelamer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

23 August 2017

Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: a randomized clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

23 August 2017

Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

23 August 2017

Atherosclerosis — An Inflammatory Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

23 August 2017

Phosphate: the new cholesterol? The role of the phosphate axis in non-uremic vascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

6 September 2017

The intact nephron hypothesis: the concept and its implications for phosphate management in CKD-related mineral and bone disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

6 September 2017

Endothelial dysfunction in chronic renal failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

6 September 2017

Lanthanum carbonate inhibits intestinal oxalate absorption and prevents nephrocalcinosis after oxalate loading in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

6 September 2017

Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

25 June 2018

Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open-label 24-month randomized clinical trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

Reduction of uric acid levels with allopurinol treatment improves endothelial function in patients with chronic kidney disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

Potential influence of sevelamer hydrochloride on responsiveness to erythropoiesis-stimulating agents in haemodialysis patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

Diabetes mellitus worsens diastolic left ventricular dysfunction in aortic stenosis through altered myocardial structure and cardiomyocyte stiffness.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

Attenuation of aortic calcification with lanthanum carbonate versus calcium-based phosphate binders in haemodialysis: A pilot randomized controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

Effect of sevelamer and calcium-based phosphate binders on coronary artery calcification and accumulation of circulating advanced glycation end products in hemodialysis patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

Benefits of sevelamer on markers of bone turnover in Taiwanese hemodialysis patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

The Suppressive Effects of Lanthanum on the Production of Inflammatory Mediators in Mice Challenged by LPS

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

Impact of phosphate binder type on coronary artery calcification in hemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

Sevelamer decreases systemic inflammation in parallel to a reduction in endotoxemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

Short-term efficacy of sevelamer versus calcium acetate in patients with chronic kidney disease stage 3-4.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

Sevelamer hydrochloride use and circulating endotoxin in hemodialysis patients: a pilot cross-sectional study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

Relationship between circulating FGF23 and total body atherosclerosis in the community

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

Fetuin-A protects against atherosclerotic calcification in CKD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

Effects of sevelamer on the progression of vascular calcification in patients on chronic haemodialysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

Either calcium carbonate or sevelamer decreases urinary oxalate excretion in chronic renal failure patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

Relation between serum phosphate level and cardiovascular event rate in people with coronary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

Effect of sevelamer on dyslipidemia and chronic inflammation in maintenance hemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

New strategy to attenuate pulse wave velocity in haemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

Long-term comparison of a calcium-free phosphate binder and calcium carbonate--phosphorus metabolism and cardiovascular calcification.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

Treatment of hyperphosphatemia with sevelamer hydrochloride in hemodialysis patients: a comparison with calcium acetate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

Bile acid binding to sevelamer HCl.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

Clinical epidemiology of cardiovascular disease in chronic renal disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

1 September 2018

Mortality in kidney disease patients treated with phosphate binders: a randomized study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

2 October 2018

Effect of sevelamer hydrochloride exposure on carotid intima media thickness in hemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

2 October 2018

The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917706

2 October 2018

Comparison of Calcium Acetate and Sevelamer on Vascular Function and Fibroblast Growth Factor 23 in CKD Patients: A Randomized Clinical Trial

1 reference

https://api.crossref.org/works/10.1177%2F1753944713513061

21 January 2018

Association between biomarkers of inflammation and left ventricular hypertrophy in moderate chronic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24327730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Control of hyperphosphatemia beyond phosphate

1 reference

https://pubmed.ncbi.nlm.nih.gov/24327730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pleiotropic effects of sevelamer beyond phosphate binding in end-stage renal disease patients: a randomized, open-label, parallel-group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24327730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship of fetuin-A with glomerular filtration rate and endothelial dysfunction in moderate-severe chronic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24327730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral artery calcifications evaluated by histology correlate to those detected by CT: relationships with fetuin-A and FGF-23

1 reference

https://pubmed.ncbi.nlm.nih.gov/24327730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of serum fetuin-A levels with mortality in dialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24327730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A gut feeling on endotoxemia: causes and consequences in chronic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24327730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversal of the adynamic bone disorder and decreased vascular calcification in chronic kidney disease by sevelamer carbonate therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24327730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibroblast growth factor 23 in hemodialysis patients: effects of phosphate binder, calcitriol and calcium concentration in the dialysate

1 reference

https://pubmed.ncbi.nlm.nih.gov/24327730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma fibroblast growth factor-23 levels are independently associated with carotid artery atherosclerosis in maintenance hemodialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24327730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community

1 reference

https://pubmed.ncbi.nlm.nih.gov/24327730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma pentosidine and total homocysteine levels in relation to change in common carotid intima-media area in the first year of dialysis therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24327730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exposure to lanthanum compound diminishes LPS-induced inflammation-associated gene expression: involvements of PKC and NF-kappaB signaling pathways

1 reference

https://pubmed.ncbi.nlm.nih.gov/24327730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperuricemia induces endothelial dysfunction via mitochondrial Na+/Ca2+ exchanger-mediated mitochondrial calcium overload

1 reference

https://pubmed.ncbi.nlm.nih.gov/24327730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulatory mechanisms in vascular calcification

1 reference

https://pubmed.ncbi.nlm.nih.gov/24327730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24327730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24327730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1177/1753944713513061

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37567574&oldid=1711346548"